BioHealth and Life Sciences Update - 6/29/16

Novavax Expands Operations with up to 850 New Hires in Maryland

Gaithersburg's Novavax, a clinical stage vaccine company developing promising
vaccines for RSV, Influenza, and Ebola announces plans to expand its operations in
Montgomery County adding up to 850 new jobs to its current 400+ workforce.

BioHealth and Life Sciences News

Gaithersburg's Emergent BioSolutions receives a BARDA contract valued at up to $21.9M
to develop and manufacture three cGMP lots of a Zika vaccine for use in a Phase 1 clinical
trial. The company also receives FDA Orphan Drug status for its BioThrax vaccine.
Rockville's GlycoMimetics' GMI-1271 receives FDA Fast Track Designation for treatment
of AML. The company also announces pricing of public offering of common stock.
Gaithersburg's Opgen closes a $10.4M private placement to advance its molecular
diagnostics and bioinformatics technology focused on multi-drug resistant organisms.
Baltimore's Lupin Limited receives FDA approvals for generic Activella and Vfend
Tablets and Vfend Oral Suspension.
Gaithersburg's Nuo Therapeutics raises $7.5M to advance its biodynamic hematogel
therapies.
Gaithersburg's GenVec, a clinical-stage gene delivery company, announces a $5M at-themarket offering.to advance its cutting-edge therapeutics and vaccines .
Germantown's Neuralstem plans to raise $1.08M and announces positive data regarding its
NSI-189 technology.
Baltimore's Cerecor announces a $1M R&D grant from the National Inst. on Drug Abuse.

Baltimore's Noxilizer announces FDA 510(k) clearance of a medical device sterilized using
the company's nitrogen dioxide sterilization process.
Germantown's Senseonics, developing a long-term, implantable continuous glucose
monitoring system, signs exclusive distribution agreement with Roche.
Rockville's MacroGenics presents data from Phase 1 study of MGD010 at EULAR 2016.
Baltimore's WellDoc announces positive results regarding use of its digital health product
and also expands its leadership team with roster of seasoned healthcare executives.
Gaithersburg's Vtesse advances Phase 2b/3 clinical trial of VTS-270 in Niemann-Pick Type
C1 Disease.
Rockville's CASI Pharmaceuticals receives approval from CFDA to conduct Phase 2
clinical trials with ENMD-2076 for Fibrolamellar Carcinoma (FLC).
Germantown's Epigenomics' Epi proColon test--the first and only FDA approved blood test
for colon cancer, is included now in the USPSTF guidelines for colorectal cancer screening.
Baltimore's Clear Guide Medical recieves a patent for its innovation image fusion product.
Rockville's ABL and REGENXBIO to manufacture HoFH treatment for human clinical trials.
Columbia's Osiris' Grafix demonstrates superior clinical outcomes compared with EpiFix.
Baltimore's eNeura, Inc. receives CE Mark label extension expanding use of SpringTMS to
include migraine prevention.
Rockville's REGENXBIO and Biogen enter exclusive license agreement for the
development of gene therapy treatments for rare genetic vision disorders.
Poolesville High School senior Anantha Sriya Reddy wins MD BioGENEius contest. .
Baltimore's Sonavex named ICOY Life Sciences Company of the year.

The Maryland Department of Commerce focuses on attracting, retaining, and

expanding businesses and creating jobs in Maryland, and also markets Maryland's many
assets to companies across the nation and abroad. The Department's Office of
BioHealth and Life Sciences supports innovative start-ups and companies focused on

animal and human health, health IT, research tools, and related technologies.

Maryland Department of Commerce

Office of BioHealth and Life Sciences
401 East Pratt Street
7th Floor | Baltimore, MD 21202
410.767.0505
9600 Gudelsky Drive
Rockville, MD 20850
240.314.6171
BioHealth.Info@Maryland.gov
Click here for BLS newsletter archives

ABOUT MARYLAND

START A BUSINESS

MOVE A BUSINESS

GROW YOUR BUSINESS FUNDING

MD BIOHEALTH AND LIFE SCIENCES DIRECTORY

MARYLAND DEPARTMENT OF COMMERCE